Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Randomized Study to Determine the Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes

NCT03227484 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03227484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03227484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Randomized Study to Determine the Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes
Lead sponsor
University Hospital Tuebingen
Phase
Phase 2
Overall status
Completed
Start date
June 9, 2017
Completion date
November 18, 2019
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

body weight, prediabetes